Computational evidence
| Protein change | ||
| AlphaMissense | 0.2946 | likely benign |
|---|---|---|
| REVEL | 0.099 | moderately benign-leaning |
| SaProt | LLR -7.52 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 1,392 bp · p 0.98 · regional, not allelic |
| Overall | ||
| CADD | 23.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 62.8% | 2 |
| East Asiangrpmax | 57.3% | 2 |
| Amishnot grpmax-eligible | 55.5% | 2 |
| European (non-Finnish) | 54% | 2 |
| Remaining individualsnot grpmax-eligible | 51.6% | 2 |
| Admixed American | 50.6% | 2 |
| Middle Eastern | 49.4% | 2 |
| Ashkenazi Jewishnot grpmax-eligible | 49.2% | 2 |
| South Asian | 48.1% | 2 |
| African / African-American | 29.1% | 3 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DUSP6
- Protein
- p.Val114Leu
- Coding
- c.340G>T
- MANE Select
- NM_001946
- dbSNP
- rs2279574
- Type
- single nucleotide variant
- Location
- chr12:89351700 (GRCh38)
- Gene constraint
- LOEUF 0.45 · pLI 0.99 (gnomAD)
- Structure
- AlphaFold pLDDT 76.13 · 2 PDB
- Residue 114
- the rhodanese domain; an α-helix; a UniProt-annotated variant site (in)
Similar variants
- DUSP6 p.Ala57Thr Uncertain significance ★★ ⚠ same condition
- DUSP6 p.Phe77Ile Uncertain significance ★★ ⚠ same condition
- DUSP6 p.Cys39Ter Pathogenic ★ same condition
- DUSP6 p.Asn189Ser Conflicting classifications of pathogenicity ★ ⚠ same condition
- DUSP6 p.Ser182Phe Conflicting classifications of pathogenicity ★ ⚠ same condition
- DUSP6 p.Ala141Asp Uncertain significance ★★ ⚠ same type
- DUSP6 p.Asp93Glu Uncertain significance ★★ ⚠ same type
- DUSP6 p.Glu32Lys Uncertain significance ★★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dusp6-p-val114leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown